Use of polypeptide zl-m-1 in the preparation of anti-hepatocellular carcinoma drugs
A ZL-M-1, anti-liver cancer technology, applied in the field of biomedicine, can solve the problems of poor stability of polypeptides to proteasomes, high toxicity of polypeptides, and high cost of production and synthesis of polypeptides
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0011] 1. The effect of ZL-M-1 on the growth of human liver cancer cells SMMC7721 in vitro
[0012] Human liver cancer cell SMMC7721 in the logarithmic growth phase was taken, and the cell concentration was adjusted to 5×10 with RPMI-1640 medium containing 10% fetal bovine serum. 4 cells / ml, add 100 μl of cell suspension in a 96-well culture plate, and add different concentrations of ZL-M-1 diluted with culture medium, (20 μl / well; final concentrations are: 0, 2, 4, 8, 10 , 12, 14, 16μg / ml), 37°C, 5% CO 2 After culturing for 24, 48, and 72 hours respectively, aspirate the supernatant, add 80 μl of fresh culture medium to each well, then add 20 μl of 5 mg / ml MTT to each well, continue to cultivate for 4 hours, centrifuge, aspirate the supernatant, add 150 μl DMSO to each well, lightly Gently shake to dissolve the formazan completely, and measure the absorbance with a microplate reader at a wavelength of 490nm. The cell viability was calculated according to literature, cell vi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com